About Genetesis
Genetesis is a company based in Mason (United States) founded in 2013 by Emmanuel Setegn, Vineet Erasala, and Peeyush Shrivastava.. Genetesis has raised $35.48 million across 6 funding rounds from investors including Wilson Sonsini Goodrich & Rosati, Mithril and Cercano Management. The company has 28 employees as of December 31, 2024. Genetesis offers products and services including CardioFlux and CardioFlux Membership.
- Headquarter Mason, United States
- Employees 28 as on 31 Dec, 2024
- Founders Emmanuel Setegn, Vineet Erasala, Peeyush Shrivastava
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genetesis, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$35.48 M (USD)
in 6 rounds
-
Latest Funding Round
$17.5 M (USD), Series C
Oct 06, 2022
-
Investors
Wilson Sonsini Goodrich & Rosati
& 11 more
-
Employee Count
28
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genetesis
Genetesis offers a comprehensive portfolio of products and services, including CardioFlux and CardioFlux Membership. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive tool for early detection of myocardial ischemia in hospitals.
Program offering access to preventive cardiac care tools and resources.
Unlock access to complete
Unlock access to complete
Funding Insights of Genetesis
Genetesis has successfully raised a total of $35.48M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $17.5 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $17.5M
-
First Round
First Round
(31 Oct 2014)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series C - Genetesis | Valuation | Mithril | |
| Oct, 2021 | Amount | Series B - Genetesis | Valuation | HealthTech Arkansas |
|
| Apr, 2020 | Amount | Series B - Genetesis | Valuation | TDK Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genetesis
Genetesis has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Wilson Sonsini Goodrich & Rosati, Mithril and Cercano Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are made in the UK and US.
|
Founded Year | Domain | Location | |
|
Early-stage sector-agnostic VC firm investing in geographies such as the US
|
Founded Year | Domain | Location | |
|
CincyTech is engaged in venture capital investments for innovative startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genetesis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genetesis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genetesis Comparisons
Competitors of Genetesis
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genetesis
Frequently Asked Questions about Genetesis
When was Genetesis founded?
Genetesis was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Genetesis located?
Genetesis is headquartered in Mason, United States. It is registered at Mason, Ohio, United States.
Who is the current CEO of Genetesis?
Peeyush Shrivastava is the current CEO of Genetesis. They have also founded this company.
Is Genetesis a funded company?
Genetesis is a funded company, having raised a total of $35.48M across 6 funding rounds to date. The company's 1st funding round was a Series B of $9.2M, raised on Oct 31, 2014.
How many employees does Genetesis have?
As of Dec 31, 2024, the latest employee count at Genetesis is 28.
What does Genetesis do?
Genetesis was founded in 2013 and is headquartered in Mason, United States. The company operates in the medical imaging sector, focusing on cardiac diagnostics. A device named CardioFlux is being developed to utilize magnetocardiography for measuring the hearts natural magnetic fields. This technology aids in the non-invasive assessment of cardiac conditions, with operations centered on device innovation and clinical applications.
What products or services does Genetesis offer?
Genetesis offers CardioFlux and CardioFlux Membership.
Who are Genetesis's investors?
Genetesis has 12 investors. Key investors include Wilson Sonsini Goodrich & Rosati, Mithril, Cercano Management, JobsOhio, and Ohio Innovation Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.